Falcon Genomics

Falcon Genomics is a biotechnology company that provides accurate diagnosis and predicts efficient and targeted treatments for cancer patients. Falcon Genomics is currently offering two services: gene expression analysis using the Affymetrix GeneAtlas system, and Falcon Genomics' patented Cancer BioChip System (CBCS), which consists of siRNA-based kits for identifying 3D tumor growth inhibitors.